Abeona Therapeutics Stock Statistic Functions Beta

ABEO Stock  USD 4.47  0.02  0.45%   
This statistic functions view applies Beta function and related studies to Abeona Therapeutics. The view highlights statistical functions describing dispersion and variability as part of broader trend and risk evaluation. Provide Time Period to run the technical study.

This analysis covers thirty-seven data points across the selected time horizon. The Beta measures systematic risk based on how returns on Abeona Therapeutics correlated with the market. If Beta is less than 0 Abeona Therapeutics generally moves in the opposite direction as compared to the market. If Abeona Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abeona Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abeona Therapeutics is generally in the same direction as the market. If Beta > 1 Abeona Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Abeona Therapeutics Technical Analysis Modules

A technical review of Abeona Therapeutics evaluates how price, volume, and momentum indicators converge or diverge to signal directional bias. Divergences between price action and indicator readings often precede meaningful reversals or acceleration.

Methodology, Assumptions & Data Sources

The Statistic Functions trend below shows where Abeona Therapeutics stands now versus the past. Year-over-year changes are the easiest way to spot turning points.

This section for Abeona Therapeutics is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Where analyst coverage exists, consensus estimates are factored in. Values may update on different source schedules.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 27th, 2026